Home
Home Page
Recent Posts
Top Active Boards
Popular Posts
Biotech Tweets
Market Tweets
Energy Industry Tweets
Official IV Sponsor Page
My Content
My Boards
My Feed
My Library
My Links
Boards Search
Groups Directory
My Network
My Favorite Posters
My Private Message Groups
My Blocked Sender List
Member Directory
Account
Email & Password
Subscription/Membership
All Account Details
My Profile
My Device Info
Sign Up
Settings
My Site Settings
My Notification Settings
BOARDS
Sign In for Filters
|
BOARDS
Become a Member
|
Sign In
Advertise With Us
Board Stats
:
329 members / 2125 guests [742]
Bristol-Myers Squibb Co.
Board
Links
(more...)
Y!
CELG MM R&D deep dive
CELG legacy IV board (still active)
CELG legacy IV board (premium)
@bmsnews (Company Twitter Account)
GoFundMe Mike Barnett Recovery Fund
BMY / Message Board
BOARD
GROUPS
Loading...
Written By
On Topic Only
--
All Messages
Hide Replies
Keyword
Subject
Between
and
Rec'd By
Authored By
Minimum Recs
Go to Msg #
MSG #
SUBJECT
TYPE
AUTHOR
SENTIMENT
RECS
DATE POSTED
11258
Re: BMO - BMY:Investor Lunch Takeaways: Steady Progress as Investors Eye 2025 Targets
GN
heckster
6
6/1/2023 12:24:59 PM
11257
Building IP: BMY Patent Appl "HETEROCYCLIC PAD4 INHIBITORS"
GN
JBWIN
1
6/1/2023 9:38:07 AM
11256
Building IP: BMY Patent Appl "SUBSTITUTED N-(METHYL-D3)PYRIDAZINE-3-CARBOXAMIDE OR...
GN
JBWIN
0
6/1/2023 9:37:25 AM
11255
Building IP: BMY Patent Appl " PRODRUGS IN THE MODULATION OF INTERLEUKIN"
GN
JBWIN
1
6/1/2023 9:36:20 AM
11254
Building IP: JUNO Patet Appl "COMBINATION OF BCMA-DIRECTED T CELL THERAPY AND AN...
GN
JBWIN
0
6/1/2023 9:35:05 AM
11253
BMO - BMY:Investor Lunch Takeaways: Steady Progress as Investors Eye 2025 Targets
GN
JBWIN
7
6/1/2023 9:13:17 AM
11252
Re: Heading to 5 handle? Unbelievable. Sitting tight. eom.
GN
Doolen
0
6/1/2023 8:00:27 AM
11251
Participation in Investor Conferences announced - 6/8 - Jeffries/6/13 GS
GN
Doolen
0
6/1/2023 7:44:03 AM
11250
Re: 9/14 R&D Day announced - see news
GN
heckster
5
5/31/2023 12:01:18 PM
11249
Re: BMY 30May2023 PR re FDA Accepts Reprotrecitinib in ROS1+ NSCLC w/PDUFA 27Nov2023
GN
JBWIN
5
5/31/2023 10:11:17 AM
Go to Msg #
About Us
•
Contact Us
•
Follow Us on Twitter
•
Members Directory
•
Help Center
•
Advertise
•
Official IV Sponsor Page
Become a Patron
© 2003-2023 Investorvillage.com. All rights reserved.
User Agreement
Financial Market Data provided by
.
Loading...